The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Aspirin‐induced activation of the NF‐κB signaling pathway: a novel mechanism for aspirin‐mediated apoptosis in colon cancer cells
Abstract
The use of aspirin and other nonsteroidal anti‐inflammatory drugs (NSAIDs) is associated with a lower risk of colorectal cancer. however, the underlying mechanism is complex and remains to be fully elucidated. NSAIDs have modulated NF‐κB in response to stimulating cytokines, but the link between NF‐κB and aspirin‐induced growth inhibition of colorectal cancer cells has yet to be thoroughly investigated. in the present study, we examined the effects of aspirin on the NF‐κB pathway and the association between these effects and apoptotic tumor cell death. we found that aspirin induced a concentration and timedependent reduction in cytoplasmic inba in colorectal cancer cells that was due to phosphorylation‐dependent, proteosome‐mediated degradation of the protein. with aspirin‐induced IκBα degradation, we observed nuclear translocation of NF‐κB, as determined by immunocytochemistry and electrophoretic mobility shift assays (emsas). the NF‐κB response to aspirin preceded cell death and was, therefore, more likely to be a cause than a consequence. to further investigate this relationship, we generated HRT18 and CT26 colon cancer cells that constitutively expressed a super‐repressor IκBα. we found that inhibition of NF‐κB nuclear translocation in these cells abrogated aspirin‐ induced apoptosis. when we investigated the cell specificity of the aspirin‐induced response, we observed both IκBα degradation and growth inhibition in a panel of colorectal cancer cells, but there was no effect in cells of noncolonic origin. thus we conclude that aspirin induces activation of NF‐κB, which is required for its anti‐tumor activity and may contribute to the protective effect of aspirin that has been observed in clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The role of cyclooxygenases in inflammation, cancer, and development
Williams, C. S., Mann, M., & DuBois, R. N. (1999) · Oncogene · doi:10.1038/sj.onc.1203286 · Cited by 1,417
Cited by
Cyclooxygenase‐independent actions of cyclooxygenase inhibitors
Tegeder, I., Pfeilschifter, J., & Geisslinger, G. (2001) · The FASEB Journal · doi:10.1096/fj.01-0390rev · Cited by 747
Nuclear factor-kappa B and cancer: its role in prevention and therapy
Bharti, A. C., & Aggarwal, B. B. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01154-1 · Cited by 510
Grösch, S., Tegeder, I., Niederberger, E., Bräutigam, L., & Geisslinger, G. (2001) · The FASEB Journal · doi:10.1096/fj.01-0299fje · Cited by 501
Anti-Inflammatory Drugs as Anticancer Agents
Zappavigna, S., Cossu, A. M., Grimaldi, A., Bocchetti, M., Ferraro, G. A., Nicoletti, G. F., Filosa, R., & Caraglia, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072605 · Cited by 395
Anti-Inflammatory Agents for Cancer Therapy
Rayburn, E. (2009) · Molecular and Cellular Pharmacology · doi:10.4255/mcpharmacol.09.05 · Cited by 341
Metadata
- Authors
- Stark, L. A., Din, F. V. N., Zwacka, R. M., & Dunlop, M. G.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2001-03-20
- Volume
- 15
- Issue
- 7
- Pages
- 1273-1275
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2130421382
- Cited by
- 191
- References
- 1
- FWCI
- 4.71
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Aspirin‐induced activation of the NF‐κB signaling pathway: a novel mechanism for aspirin‐mediated apoptosis in colon cancer cells. https://app.cochat.ai/papers/10.1096/fj.00-0529fje
- The paper
- Stark, L. A., Din, F. V. N., Zwacka, R. M., & Dunlop, M. G. (2001). Aspirin‐induced activation of the NF‐κB signaling pathway: a novel mechanism for aspirin‐mediated apoptosis in colon cancer cells. The FASEB Journal. https://doi.org/10.1096/fj.00-0529fje
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.